Last Fall, we brought together social impact leaders from top pharmaceutical companies to explore the unique challenges and opportunities shaping the industry. This Spring, we’ll convene again to explore the most pressing needs attendees are facing in the current environmental context, and identify commonalities through the conversation that we can address through action afterwards. Potential focus areas for the conversation are reputational risk and/or navigating the current governmental shifts in health policy.

To encourage open and candid discussion, this event follows the Chatham House Rule – attendees may share insights from the conversation but cannot attribute statements to specific individuals or organizations. This ensures a trusted space for thoughtful dialogue and deeper insights.